Back to Search
Start Over
Non-alcoholic fatty liver disease: a sign of systemic disease
- Publication Year :
- 2017
- Publisher :
- Elsevier, 2017.
-
Abstract
- Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and leading cause of cirrhosis in the United States and developed countries. NAFLD is closely associated with obesity, insulin resistance and metabolic syndrome, significantly contributing to the exacerbation of the latter. Although NAFLD represents the hepatic component of metabolic syndrome, it can also be found in patients prior to their presentation with other manifestations of the syndrome. The pathogenesis of NAFLD is complex and closely intertwined with insulin resistance and obesity. Several mechanisms are undoubtedly involved in its pathogenesis and progression. In this review, we bring together the current understanding of the pathogenesis that makes NAFLD a systemic disease.
- Subjects :
- 0301 basic medicine
CHRONIC KIDNEY-DISEASE
medicine.medical_specialty
Cirrhosis
MUSCLE INSULIN-RESISTANCE
Exacerbation
Endocrinology, Diabetes and Metabolism
LIPOPROTEIN-LIPASE
Disease
HEPATIC STELLATE CELLS
digestive system
Pathogenesis
03 medical and health sciences
Liver disease
Endocrinology & Metabolism
Endocrinology
Insulin resistance
Non-alcoholic Fatty Liver Disease
Internal medicine
Fatty liver
NAFLD
medicine
Humans
OBESE ZUCKER RAT
Obesity
METABOLIC SYNDROME
GENE-EXPRESSION
Science & Technology
NITRIC-OXIDE
business.industry
NASH
nutritional and metabolic diseases
1103 Clinical Sciences
medicine.disease
digestive system diseases
030104 developmental biology
ADIPOSE-TISSUE
CARDIOVASCULAR-DISEASE
Metabolic syndrome
business
Life Sciences & Biomedicine
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....4e6768bd7d3fcd7f8311bb9efd730965